Yunbiao Ling, MD

Titles

Professor of Hepatobiliary Surgery Department.

Master supervisor of Hepatobiliary Surgery Department

Research Interests

Surgical treatment and compositive treatment of liver cancer;

Surgical treatment of portal hypertension;

Surgical treatment of hepatic, biliary, pancreatic and splenic diseases

He has been engaged in clinical and basic research work of primary liver cancer for more than 20 years. He accumulated rich clinical experience in surgery treatment,  ablation treatment and compositive treatment of liver cancer. Also, he has plenty of experience about biliary stone, portal hypetension and pancreatic cancer.

Education and Experience

1993~1998: Resident, General Surgery, The 3rd Affiliated Hospital of Sun Yat-Sen University;

1998~2005: Visiting staff, Hepatobiliary Surgery Department, The 3rd Affiliated Hospital of Sun Yat-Sen University;

2005~2013: Associate senior doctor, Hepatobiliary Surgery Department, The 3rd Affiliated Hospital of Sun Yat-Sen University;

2009.6: Trained in Hospital of Linchoepin University, Sweden;

2010.12-2011.2: Trained in Hospital of Strasund, Germany.

Honors and Awards

Publications

1. Tang ZF, Ling YB, Lin N, Hao Z, Xu RY.Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.World J Gastroenterol. 2007 Apr 21;13(15):2223-8.

2.XU Ruiyun , LING Yunbiao, YANG Hongzhi,etc. The curative effects of gan-xian-fang for the treatment of hepatic fibrosis Resulted from Hepatitis B: a prospective and randomized double blind controlled trial. Chin Med J 2001,114(10):174-186.

Contact

Department of Hepatobiliary Surgery, The 3rd Affiliated Hospital of Sun Yat-Sen University. No. 600 TianHe Road, Guangzhou, Guangdong, China

Post Code: 510630

Email: lingyunbill@yahoo.com